Mundipharma empowers global healthcare access with acquisition of Rezafungin rights
The acquisition by Mundipharma aims to intensifying focus on infectious diseases
In a recent announcement, Mundipharma, a leading global pharmaceutical company, has announced its acquisition...
MHRA approves Rezzayo to treat invasive candidiasis
More than half of the patients who were given a weekly dose of the medicine were cured at day 14
The Medicines and Healthcare products...